Response to commentaries on 'Alpha calculus in clinical trials: considerations for the new millennium'

Stat Med. 2000 Mar 30;19(6):795-9. doi: 10.1002/(sici)1097-0258(20000330)19:6<795::aid-sim521>3.0.co;2-g.
No abstract available